When segregating the cases into luminal and non-luminal cancers, DCLK1 expression was associated with better DFS significantly in luminal cancers (log-rank=5.883, p = 0.015) but not in non-luminal cancers (log-rank=0.389, p = 0.533). Here, DCLK1 is linked to cancer.